|LETTER TO EDITOR
|Year : 2023 | Volume
| Issue : 1 | Page : 55-56
Incidence of stroke in a population affected by COVID-19 in Veracruz, México
Luis Del Carpio-Orantes, Ishar Solís-Sánchez, Nancy Patricia Moreno-Aldama, Andrés Aguilar-Silva, Sergio García-Méndez, Jesús Salvador Sánchez-Díaz
Study Group for the Diagnosis and Treatment of COVID-19 in Veracruz, Mexico
|Date of Submission||01-Nov-2022|
|Date of Decision||01-Dec-2022|
|Date of Acceptance||07-Dec-2022|
|Date of Web Publication||24-Mar-2023|
Luis Del Carpio-Orantes
Study Group for the Diagnosis and Treatment of COVID-19 in Veracruz
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Carpio-Orantes LD, Solís-Sánchez I, Moreno-Aldama NP, Aguilar-Silva A, García-Méndez S, Sánchez-Díaz JS. Incidence of stroke in a population affected by COVID-19 in Veracruz, México. Brain Circ 2023;9:55-6
|How to cite this URL:|
Carpio-Orantes LD, Solís-Sánchez I, Moreno-Aldama NP, Aguilar-Silva A, García-Méndez S, Sánchez-Díaz JS. Incidence of stroke in a population affected by COVID-19 in Veracruz, México. Brain Circ [serial online] 2023 [cited 2023 Jun 4];9:55-6. Available from: http://www.braincirculation.org/text.asp?2023/9/1/55/372450
One of the main complications of COVID-19 is the thrombotic events reported with different incidences in the different case series, although those of the central nervous system are rare.
A meta-analysis carried out on more than 108,500 patients showed a low incidence of stroke in patients with COVID in the order of 1.4%, despite being a population with important cardiovascular risk factors; another systematic review and meta-analysis carried out in 26,691 patients showed an incidence of ischemic stroke of 2%. There was a 1.48% stroke rate across 119,967 COVID-19 hospitalizations.,,
In the Philippines, the incidence of stroke among patients with COVID-19 was 3.4% (n = 367). In the Mexican Registry of Neurological Manifestations in Patients with Confirmed COVID-19, the incidence of stroke was reported to be 19%. Cerebrovascular insults were the most common severe neurologic manifestations. Most countries in Latin-American (Argentina, Brasil, Chile, Colombia, Peru y Paraguay) reported mild decreases in all-type stroke admissions during the COVID-19 period, except Mexico, where admissions significantly increased in 2020, probably due to a redistribution of admissions to hospitals classified as non-COVID-19 centers.,,
Some authors suggest in the pathogenesis the presence of hypercoagulable states associated with COVID and manifestations due to the elevation of markers such as D-dimer, fibrinogen, ferritin, and thrombocytopenia.
To identify the incidence of stroke in patients affected by COVID-19 in Veracruz, Mexico, from April to October 2021, we made a descriptive and retrospective study, in which strokes presented by patients who suffered from COVID-19 are analyzed.
Data from 1,212 patients diagnosed with COVID-19 are included from a single hospital center, making the diagnosis of COVID-19 using polymerase chain reaction-reverse transcription or COVID antigen test, 641 (53%) men and 571 (47%) women, with a mean age of 49 years. 663 (54.7%) patients suffered from some chronic disease, systemic arterial hypertension was the most common comorbidity (29.2%), followed by diabetes (29.1%), obesity (13.9%), cardiovascular disease (5.4%), asthma (4.5%), chronic kidney disease (3.8%), and COPD (2.1%). The most frequent neurological symptoms were headache (83%), anosmia (75%), dysgeusia (75%), myalgia (68%), and somnolence (50%). This high incidence of neurological symptoms speaks of the high neurotropism of the virus and its predilection for frontal involvement, which explains many of the reported symptoms and for which there is already reported evidence.
Regarding the presence of stroke, whose diagnosis was made by clinical picture corroborated by simple cranial computed tomography, we found two cases of stroke, onecase of retinal artery thrombosis right eye, and three cases of transient cerebral ischemia without repercussion reported, all presented in the acute stage of COVID-19; the patients who presented cerebral vascular events associated with COVID-19, 50% were female, with an average age of 52 years. About 67% presented the triad of diabetes, hypertension and obesity. He highlighted that the more severe the neurological involvement, the greater the inflammation and thrombotic risk data documented; 83% had a good prognosis [Table 1]. Taking into account the population of the state of Veracruz, which is 8,062,579 inhabitants in 2021, the incidence of cerebrovascular thrombotic events is 0.6 cases per million inhabitants.
We consider that the incidence of stroke is low even though more than half of the patients presented some chronic comorbidity, highlighting the presence of arterial hypertension, diabetes, and obesity, despite this the events of stroke were of low incidence and there were others related, such as transient cerebral ischemia that stands out in the same way.
We also consider that the hospital conversion due to the COVID-19 pandemic affected the diagnosis and treatment protocols of other entities such as stroke, which could at some point reduce the detection of said entity and other non- COVID diseases, which could be reflected in a low incidence of cases.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Nannoni S, de Groot R, Bell S, Markus HS. Stroke in COVID-19: A systematic review and meta-analysis. Int J Stroke 2021;16:137-49.
Luo W, Liu X, Bao K, Huang C. Ischemic stroke associated with COVID-19: A systematic review and meta-analysis. J Neurol 2022;269:1731-40.
Nogueira RG, Qureshi MM, Abdalkader M, Martins SO, Yamagami H, Qiu Z, et al.
Global impact of COVID-19 on stroke care and IV thrombolysis. Neurology 2021;96:e2824-38.
Jamora RD, Prado MB Jr., Anlacan VM, Sy MC, Espiritu AI. Incidence and risk factors for stroke in patients with COVID-19 in the Philippines: An analysis of 10,881 cases. J Stroke Cerebrovasc Dis 2022;31:106776.
Delgado-García G, Dávila-Maldonado L, González-Duarte A. Mexican registry of neurologic manifestations in patients with confirmed COVID-19: Preliminary results (3010). Neurology 2021;96 Suppl 15:3010.
Pujol-Lereis VA, Flores A, Barboza MA, Abanto-Argomedo C, Amaya P, Bayona H, et al.
COVID-19 lockdown effects on acute stroke care in Latin America. J Stroke Cerebrovasc Dis 2021;30:105985.
Zhang S, Zhang J, Wang C, Chen X, Zhao X, Jing H, et al.
COVID19 and ischemic stroke: Mechanisms of hypercoagulability (Review). Int J Mol Med 2021;47:21.
Toniolo S, Di Lorenzo F, Scarioni M, Frederiksen KS, Nobili F. Is the frontal lobe the primary target of SARS-CoV-2? J Alzheimers Dis 2021;81:75-81.